Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of CPI-0610 in Myelofibrosis (MF) (MANIFEST-2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04603495
Recruitment Status : Recruiting
First Posted : October 26, 2020
Last Update Posted : September 21, 2021
Sponsor:
Information provided by (Responsible Party):
Constellation Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2022
Estimated Study Completion Date : September 2023